Elequin Capital’s iShares China Large-Cap ETF FXI Stock Holding History

Elequin Capital’s Portfolio FXI Stock Details FXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,011	Closed	-$147K	–	239
2025 Q2	$147K	Buy	4,011 +35	+0.9%	+$1.23K	0.02%	189
2025 Q1	$143K	Sell	3,976 -2,353	-37%	-$79.7K	0.02%	108
2024 Q4	$193K	Buy	+6,329	New	+$200K	0.02%	79

Other funds holding FXI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CI Investments Inc Toronto, Ontario, Canada $31.2B AUM 40.61% 1-Year Est. Return

Spear Holdings Dubai, United Arab Emirates $1.68B AUM 4.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Elequin Capital's FXI Position: Q3 2025 in Review

Elequin Capital sold out of iShares China Large-Cap ETF (FXI) in Q3 2025, closing a stake of 4,011 shares — an estimated $147K sold.

Elequin Capital first reported a position in FXI in Q4 2024 and held it in 3 quarters. The position peaked at $193K in Q4 2024. 389 funds tracked by Wall St. Rank hold FXI as of Q3 2025.

Elequin Capital reported no remaining iShares China Large-Cap ETF position as of Q3 2025 after selling out during the quarter.
Elequin Capital sold 4,011 iShares China Large-Cap ETF shares in Q3 2025, an estimated $147K.
Elequin Capital first reported a position in iShares China Large-Cap ETF in Q4 2024 and held it in 3 quarters.
Elequin Capital's iShares China Large-Cap ETF position peaked at $193K in Q4 2024.
389 funds tracked by Wall St. Rank held iShares China Large-Cap ETF as of Q3 2025.

Based on Elequin Capital's 13F filing for Q3 2025, filed 14 Nov 2025.